CD19 and neoplasm: Compared with the CB T group and CD19-negative cell line K562 group, CB CD19-CAR T cells mediated cytotoxicity against the CFSE-labelled BV173 cells (P < 0.05, n = 3; Figures 2A, B), indicating that CB T cells expressing CAR constructs were able to eliminate tumor cell.